Menopause is clinically diagnosed as a condition when a woman has not menstruated for
one year. During the menopausal transition period, there is an emergence of various lipid …

The nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3)
inflammasome is an important part of the natural immune system that plays an important role …

Osteoporosis (OP) is characterized by decreased trabecular bone volume and
microarchitectural deterioration in the medullary cavity. Urolithin A (UA) is a biologically …

An estimated 20% of women experience depression at some point during menopause.
Hormone replacement therapy (HRT), as the main therapy for depression and other …

Ageing and menopause contribute to endothelial dysfunction, causing impaired cerebral
perfusion, which is in turn associated with accelerated cognitive decline. In a 14-week pilot …

The prevalence of osteoporosis among women aged 50 y and older is expected to reach
13.6 million by 2030. Alternative nonpharmaceutical agents for osteoporosis, including …

Breast cancer therapies have made significant strides in improving survival for patients over
the past decades. However, recurrence and drug resistance continue to challenge long-term …

Iron overload has been found very common in diseases such as hereditary
hemochromatosis, thalassemia, and sickle cell disease and in healthy postmenopausal …

Background Proinflammatory cytokines are implicated in the pathophysiology of
postmenopausal bone loss. Clinical studies demonstrate that prunes prevent bone mineral …

Nutrient patterns (NPs) and the synergistic effect between nutrients have been shown to be
associated with changes in bone mineral density (BMD). This study aimed to identify NPs …